Early intervention with high-efficacy disease-modifying therapy (HE DMT) may be the best strategy to delay irreversible neurological damage and progression of multiple sclerosis …
BA Singer, J Feng, H Chiong-Rivero - Journal of Neurology, 2024 - Springer
Multiple sclerosis (MS) is characterized by progressive neuroinflammation and neurodegeneration from disease onset that, if left untreated, can result in the accumulation …
H Inojosa, D Schriefer, NH Ness, A Dillenseger… - Journal of …, 2025 - Springer
Background Natalizumab (NAT) is an established disease-modifying therapy (DMT) for highly active multiple sclerosis (MS). However, its use involves complex decision-making …
P Naval-Baudin, P Arroyo-Pereiro, C Majós - European Radiology, 2024 - Springer
Multiple sclerosis (MS) is a degenerative and inflammatory central nervous system disease. It predominantly affects younger adults, can be severely disabling, and has a prolonged …